WHO ICTRP trial
WT1 peptide vaccine study after "Adoptive transfer of lymphocytes transduced…
JPRN-UMIN000017431 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000017431 |
|---|---|
| Public title | WT1 peptide vaccine study after "Adoptive transfer of lymphocytes transduced with WT1-specific TCR gene" |
| Scientific title | WT1 peptide vaccine study after "Adoptive transfer of lymphocytes transduced with WT1-specific TCR gene" - WT1 peptide vaccine study after "Adoptive transfer of lymphocytes transduced with WT1-specific TCR gene" |
| Primary sponsor | Mie University Graduate School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Acute myelogeous lekemia, Myelodysplastic syndrome |
| Interventions | subcutaneous injection of WT1 peptide, 300microgram mixed with Montanide ISA-51 VG |
| Registration date | Jun 5, 2015 |
| Target size | 9 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: